{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:33:53Z","timestamp":1759530833163},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.toxlet.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T15:13:39Z","timestamp":1476890019000},"page":"58-67","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development"],"prefix":"10.1016","volume":"263","author":[{"given":"M.Teresa","family":"Donato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"L\u00f3pez-Riera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"G\u00f3mez-Lech\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiro","family":"Jover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2016.10.008_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"Aranha","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.taap.2013.11.022","article-title":"Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans","volume":"275","author":"Atienzar","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0020","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0025","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0030","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.36591","article-title":"The human bile salt export pump: characterization of substrate specificity and identification of inhibitors","volume":"123","author":"Byrne","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","article-title":"FDA-approved drug labeling for the study of drug-induced liver injury","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-1119(00)00518-7","article-title":"Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha)","volume":"262","author":"Chiang","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0045","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cbi.2009.07.019","article-title":"Cytometric analysis for drug-induced steatosis in HepG2 cells","volume":"181","author":"Donato","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1087057111427586","article-title":"High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay","volume":"17","author":"Donato","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0070","first-page":"64","article-title":"Bioequivalence of two oral formulations of glyburide (glibenclamide)","volume":"50","author":"Flores-Murrieta","year":"2007","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(02)00107-1","article-title":"Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan","volume":"37","author":"Fouassier","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0080","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1021\/pr200629p","article-title":"A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations","volume":"10","author":"Garcia-Canaveras","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.113.054189","article-title":"The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity","volume":"42","author":"Garzel","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0090","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/00498250600674352","article-title":"Cryopreservation of rat, dog and human hepatocytes: influence of preculture and cryoprotectants on recovery, cytochrome P450 activities and induction upon thawing","volume":"36","author":"Gomez-Lechon","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0100","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.tiv.2010.07.018","article-title":"Mechanism-based selection of compounds for the development of innovative in vitro approaches to hepatotoxicity studies in the LIINTOP project","volume":"24","author":"Gomez-Lechon","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxlet.2013.09.019","article-title":"Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes","volume":"224","author":"Guo","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/15376516.2015.1033074","article-title":"The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid\/rifampicin-induced hepatotoxicity","volume":"25","author":"Guo","year":"2015","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","article-title":"The sodium bile salt cotransport family SLC10","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0125","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1021\/acs.chemrestox.5b00201","article-title":"Inhibition of MDR3 activity in human hepatocytes by drugs associated with liver injury","volume":"28","author":"He","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPG.0000000000000774","article-title":"Serum bile acid levels in children with nonalcoholic fatty liver disease","volume":"61","author":"Jahnel","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0140","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s10620-013-2747-1","article-title":"Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats","volume":"58","author":"Jia","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/mend.14.1.0409","article-title":"The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution","volume":"14","author":"Jones","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0150","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s005350070044","article-title":"Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance","volume":"35","author":"Kamisako","year":"2000","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0155","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.tiv.2011.11.002","article-title":"BSEP inhibition: in vitro screens to assess cholestatic potential of drugs","volume":"26","author":"Kis","year":"2012","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/dmd.113.054304","article-title":"Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4","volume":"42","author":"Kock","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/00498259409043224","article-title":"Collagen gel immobilization: a useful cell culture technique for long-term metabolic studies on human hepatocytes","volume":"24","author":"Koebe","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfg217","article-title":"Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats","volume":"76","author":"Kostrubsky","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/toxsci\/kfr339","article-title":"Evaluation of drugs with specific organ toxicities in organ-specific cell lines","volume":"126","author":"Lin","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0190","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.106.102657","article-title":"Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes","volume":"318","author":"McRae","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0200","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0205","doi-asserted-by":"crossref","first-page":"954781","DOI":"10.1155\/2014\/954781","article-title":"Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts","volume":"2014","author":"Morita","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0210","article-title":"The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease","author":"Okushin","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0215","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2004.06.001","article-title":"Mitochondrially-mediated toxicity of bile acids","volume":"203","author":"Palmeira","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0225","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0230","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vascn.2013.08.001","article-title":"A high content screening assay to predict human drug-induced liver injury during drug discovery","volume":"68","author":"Persson","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0235","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/KFS197","article-title":"Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria","volume":"129","author":"Porceddu","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0245","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0250","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.113.054205","article-title":"Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump","volume":"42","author":"Rodrigues","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0255","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0260","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/135965350801300415","article-title":"Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women","volume":"13","author":"Sekar","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/03602532.2012.748793","article-title":"Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver","volume":"45","author":"Staudinger","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0270","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/17425255.2011.557067","article-title":"Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis","volume":"7","author":"Stieger","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","article-title":"Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs","volume":"127","author":"Tolosa","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0280","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00204-014-1334-3","article-title":"High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins","volume":"89","author":"Tolosa","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0290","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/jpet.114.221564","article-title":"Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury","volume":"353","author":"Yang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2016.10.008_bib0295","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.110.067256","article-title":"Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3\/ABCB4","volume":"79","author":"Yoshikado","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"Suppl. (4)","key":"10.1016\/j.toxlet.2016.10.008_bib0300","first-page":"S467","article-title":"Boldine attenuates cholestasis associated with nonalcoholic fatty liver disease in hereditary hypertriglyceridemic rats fed by high-sucrose diet","volume":"64","author":"Zagorova","year":"2015","journal-title":"Physiol. Res.\/Academia Scientiarum Bohemoslovaca"},{"key":"10.1016\/j.toxlet.2016.10.008_bib0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000365003","article-title":"Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury","volume":"90","author":"Zollner","year":"2014","journal-title":"Digestion"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416332726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416332726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T19:09:24Z","timestamp":1657480164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427416332726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":61,"alternative-id":["S0378427416332726"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.10.008","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}